LINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 133
EU - Europa 132
AS - Asia 62
AF - Africa 8
SA - Sud America 4
Totale 339
Nazione #
US - Stati Uniti d'America 132
FI - Finlandia 31
IT - Italia 28
DE - Germania 25
HK - Hong Kong 23
SG - Singapore 19
CN - Cina 16
GB - Regno Unito 8
IE - Irlanda 7
MK - Macedonia 7
EG - Egitto 6
PL - Polonia 6
UA - Ucraina 5
CZ - Repubblica Ceca 4
PH - Filippine 4
BR - Brasile 3
GR - Grecia 3
CH - Svizzera 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
ES - Italia 1
MX - Messico 1
NL - Olanda 1
PE - Perù 1
PT - Portogallo 1
SE - Svezia 1
UG - Uganda 1
Totale 339
Città #
Helsinki 28
Hong Kong 22
Fairfield 18
New York 16
Munich 9
Shanghai 9
Cambridge 8
Chandler 8
Princeton 8
Ashburn 7
Beijing 7
Dublin 7
Singapore 7
Warsaw 6
Wilmington 5
Alexandria 4
Brescia 4
Brno 4
Woodbridge 4
Ann Arbor 3
Curitiba 3
Duncan 3
Houston 3
Jacksonville 3
Lappeenranta 3
Milan 3
Seattle 3
Skopje 3
Cairo 2
Cosenza 2
Manerbio 2
Motta Baluffi 2
Quezon City 2
Redwood City 2
Rome 2
San Diego 2
Abidjan 1
Amsterdam 1
Atlanta 1
Cagayan de Oro 1
Coimbra 1
Des Moines 1
Gunzenhausen 1
London 1
Los Angeles 1
Madrid 1
Magdeburg 1
Mountain View 1
New Bedfont 1
Petriolo 1
Prescot 1
Redmond 1
Soncino 1
Tower Hamlets 1
Zurich 1
Totale 243
Nome #
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 102
“APS pregnancy – The offspring” 33
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 30
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies. 30
Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys 25
Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes 21
COVID-19 vaccine safety during the antenatal period in women with idiopathic inflammatory myopathies 20
Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis 18
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 14
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 12
Management of pregnancy in autoimmune rheumatic diseases: maternal disease course, gestational and neonatal outcomes and use of medications in the prospectiveItalian P-RHEUM.it study 9
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study 9
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 9
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey 7
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study 5
Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group 5
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys 4
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys 3
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 2
Totale 358
Categoria #
all - tutte 3.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202151 0 5 4 6 0 3 6 1 9 8 6 3
2021/202268 12 16 7 1 1 3 3 2 2 5 7 9
2022/202347 4 0 2 0 4 16 0 4 9 0 4 4
2023/2024170 8 8 17 11 4 21 5 6 31 11 7 41
2024/202522 6 16 0 0 0 0 0 0 0 0 0 0
Totale 358